Q1 2024 Earnings Call Transcript Haleon plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...

GSK said in the first quarter of 2024, the sales of Specialty Medicines increased, driven by strong HIV and Oncology ...

Trial planning and execution to proceed as planned WASHINGTON, May 02, 2024 (GLOBE NEWSWIRE) -- 60, Inc. (NASDAQ: SXTP; SXTPW ...

Buying “medical-grade” skin care could be a huge waste of money. And it’s not your fault if you didn’t know this—I’ve been ...

“The decision not to award a pay increase based on age could be discriminatory if the employee can show that a real or ...

By Clare Nuttall in Glasgow In the 20 years since the first eight countries from Central and Southeast Europe joined the ...

We propose a transparent framework for CMS to implement Medicare drug price negotiation in a manner that results in credible, ...

May 1, 2024 Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.2503, expectations were $0.21.

A total of 128 trials with 141 comparisons of a new drug and comparator were included in the sample, with 47,050 patients.

Experienced cannabis consumers generally agree that the Entourage Effect produces a much stronger effect. Kinloch Wellness ...

Psilocybin—the active ingredient in "magic" mushrooms—is a more effective treatment for symptoms of depression than controls, providing further support for its potential as an antidepressant, suggests ...